Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism
Yoshinori Matsumoto, … , Carsten Bergmann, Robert Rottapel
Yoshinori Matsumoto, … , Carsten Bergmann, Robert Rottapel
Published June 5, 2017
Citation Information: J Clin Invest. 2017;127(7):2612-2625. https://doi.org/10.1172/JCI92233.
View: Text | PDF
Research Article Bone biology Cell biology

Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism

  • Text
  • PDF
Abstract

Cleidocranial dysplasia (CCD) is an autosomal dominant human disorder characterized by abnormal bone development that is mainly due to defective intramembranous bone formation by osteoblasts. Here, we describe a mouse strain lacking the E3 ubiquitin ligase RNF146 that shows phenotypic similarities to CCD. Loss of RNF146 stabilized its substrate AXIN1, leading to impairment of WNT3a-induced β-catenin activation and reduced Fgf18 expression in osteoblasts. We show that FGF18 induces transcriptional coactivator with PDZ-binding motif (TAZ) expression, which is required for osteoblast proliferation and differentiation through transcriptional enhancer associate domain (TEAD) and runt-related transcription factor 2 (RUNX2) transcription factors, respectively. Finally, we demonstrate that adipogenesis is enhanced in Rnf146–/– mouse embryonic fibroblasts. Moreover, mice with loss of RNF146 within the osteoblast lineage had increased fat stores and were glucose intolerant with severe osteopenia because of defective osteoblastogenesis and subsequent impaired osteocalcin production. These findings indicate that RNF146 is required to coordinate β-catenin signaling within the osteoblast lineage during embryonic and postnatal bone development.

Authors

Yoshinori Matsumoto, Jose La Rose, Melissa Lim, Hibret A. Adissu, Napoleon Law, Xiaohong Mao, Feng Cong, Paula Mera, Gerard Karsenty, David Goltzman, Adele Changoor, Lucia Zhang, Megan Stajkowski, Marc D. Grynpas, Carsten Bergmann, Robert Rottapel

×

Figure 2

Osteoblast defect causes osteopenia in Rnf146fl/fl Osx-Cre mice.

Options: View larger image (or click on image) Download as PowerPoint
Osteoblast defect causes osteopenia in Rnf146fl/fl Osx-Cre mice.
(A) μCT...
(A) μCT reconstruction of the trabecular region below the distal femur growth plate (top panels) and the cortical region of midshaft femurs (bottom panels) of 12-week-old Rnf146fl/fl (WT) and Rnf146fl/fl Osx-Cre (KO) mice. (B–G) μCT-derived measurements of trabecular bone volume (BV/TV) (B), trabecular bone mineral density (C), trabecular number (D), trabecular separation (E), cortical bone volume (BV/TV) (F), and cortical thickness (G) of 12-week-old Rnf146fl/fl and Rnf146fl/fl Osx-Cre mice. n = 5–6. (H–J) Histomorphometric analysis of tibial trabecular bone volume per total volume (H), osteoid surface per bone surface (OS/BS) (I), and osteoblast number per bone surface (N.Ob/BS) (J) of 12-week-old Rnf146fl/fl and Rnf146fl/fl Osx-Cre mice. n = 6–7. (K–M) Dynamic histomorphometric analysis of tibial trabecular bone formation rate (BFR/BS) (K), mineral apposition rate (MAR) (L), and mineralizing surface (MS/BS) (M) of 12-week-old Rnf146fl/fl and Rnf146fl/fl Osx-Cre mice. n = 5–7. (N and O) Histomorphometric analysis of osteoclast surface per bone surface (Oc.S/BS) (N) and osteoclast number per bone surface (N.Oc/BS) (O) of 12-week-old Rnf146fl/fl and Rnf146fl/fl Osx-Cre mice. n = 6–7. P values were determined by unpaired t test. Data are presented as mean ± SEM. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts